| abstract |
The present invention relates to a medicinal biosoluble/bioerodible hydrogel system. The medicinal biosoluble/bioerodible hydrogel system optionally contains active pharmaceutical ingredients, wherein the pharmaceutical composition is close to the lactation The animal turns from liquid to gel at body temperature. These compositions may contain reversible gelling materials such as methyl cellulose and rheology modifiers such as citric acid/citrate. |